TABLE 3.
Preclinical studies for the p62 vaccine safety.
| Study | Animals/doses | Conclusion |
|---|---|---|
| Acute i.m. and i.p. toxicity | Rats, mice, guinea pigs 1, 5, 10, 50 ETD | No acute toxicity observed |
| Chronic toxicity upon i.m. daily administration for 90 days | Rats –1,5,10, 50 ETD | Low hazard |
| Dogs –1, 10 ETD | Low toxicity | |
| Allergic activity | Guinea pigs, 1, 10 ETD | No anaphylactic shock or local allergic reaction |
| Immunological safety | Mice, 1,10 ETD, 5 times i.m | No effect on B- and T-cell response |
| Embryotoxicity and teratogenicity | Rats, 1, 10 ETD, 5-times i.m. | No embryotoxicity or teratogenicity |
ETD—effective therapeutic dose.